Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Positive improvement in palatability of metabolic formula with the use of miraculin protein in patients with inborn errors of metabolism and healthy adults
Indexado
WoS WOS:000581101500011
SciELO S0717-75182020000500801
DOI 10.4067/S0717-75182020000500801
Año 2020
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



ABSTRACT As palatability of medical formulas has been documented as unpleasant, new options are required to improve acceptance and adherence in people with inborn errors of metabolism (IEM). Miracle fruit (Synsepalum dulcificum) has a glycoprotein named miraculin that transforms a sour, bitter taste such as the one found in metabolic formula, into a sweet perception. The objective of this work is to analyze the response in the taste perception of metabolic formula with the use of the miraculin tablets in patients with IEM and healthy adults. To test this hypothesis a prospective, longitudinal, quasi-experimental, analytical study was performed. Patients with IEM and healthy adults were recruited. All participants assessed 3 different liquids (lemon, apple cider vinegar and metabolic formula) before and after the administration of miraculin tablets and completed a questionnaire. The sensory responses were evaluated using hedonic scales, analyzed with nonparametric tests for paired data. Seven patients with IEM and 14 healthy subjects were included. After miraculin intake 57% of patients (Z ≤ -1.89 p= 0.059) and healthy adults (Z≤ -2.31 p= 0.021) had a positive change in their taste perception. The absolute frequency of patients who did not like the metabolic formula decreased from 4 to 1, and in patients who liked it or loved, it increased from 0 to 2 and from 0 to 1 respectively; the frequency of patients who perceived the metabolic formula as indifferent or hated it, did not change. Response in taste perception had a positive change of 57% in both groups. The use of miraculin tablets may improve palatability of metabolic formula.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Nutrition & Dietetics
Scopus
Sin Disciplinas
SciELO
Health Sciences

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 López, Lizbeth Mujer Instituto Nacional de Pediatría - México
Secretaria Salud Mexico - México
Secretaria de Salud de México - México
2 Vela, Marcela Mujer Instituto Nacional de Pediatría - México
Secretaria Salud Mexico - México
Secretaria de Salud de México - México
3 Ibarra-Gonzalez, Isabel Mujer UNAM-Instituto Nacional de Pediatría - México
Secretaria de Salud de México - México
Secretaria Salud Mexico - México
Instituto Nacional de Pediatría - México
4 Díaz, Luisa Mujer Instituto Nacional de Pediatría - México
Secretaria de Salud de México - México
Secretaria Salud Mexico - México
5 Belmont, Leticia Mujer Instituto Nacional de Pediatría - México
Secretaria Salud Mexico - México
Secretaria de Salud de México - México
6 Guillén, Sara Mujer Instituto Nacional de Pediatría - México
Secretaria Salud Mexico - México
Secretaria de Salud de México - México

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Instituto Nacional de Pediatria ("Recursos Fiscales del Programa") Ministry of Health, Mexico

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
We thank the patients and also the healthy subjects for participating in the study. This work was supported by Research Funding from the Instituto Nacional de Pediatria ("Recursos Fiscales del Programa E022") Ministry of Health, Mexico. LML, MVA, IIG, LDG, LBM, SGL declare no conflicts of interest.

Muestra la fuente de financiamiento declarada en la publicación.